Clinical AI
Steve Jobs' Son Launches $350 Million Bet That AI Can Crack Cancer's Toughest Targets
Reed Jobs' Yosemite fund backs 25 companies using artificial intelligence to design therapies for previously "undruggable" tumors, blending CRISPR, epigenetic editing, and computational biology with a unique philanthropic model.
Health AI Central Editorial Team·July 14, 2026